Adicet Bio, Inc. — Director's Dealing 2019

Dec 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-12-10

Reporting Person: PureTech Health LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-10	Common Stock	S	336561	$1.2588	Disposed	8932795	Direct
2019-12-11	Common Stock	S	59921	$1.25	Disposed	8872874	Direct
2019-12-12	Common Stock	S	385884	$1.2499	Disposed	8486990	Direct

Footnotes

F1: Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.29, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.255, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.